Market revenue in 2022 | USD 206.8 million |
Market revenue in 2030 | USD 459.5 million |
Growth rate | 10.5% (CAGR from 2022 to 2030) |
Largest segment | Transmitter & receiver |
Fastest growing segment | Insulin Pumps |
Historical data | 2018 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Sensors, Transmitter & Receiver, Insulin Pumps |
Key market players worldwide | DexCom Inc, Abbott Laboratories, Medtronic PLC, Ypsomed Holding AG, Senseonics Holdings Inc, A.Menarini Diagnostics, Signos |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to continuous glucose monitoring devices market will help companies and investors design strategic landscapes.
Transmitter & receiver was the largest segment with a revenue share of 37.28% in 2022. Horizon Databook has segmented the Japan continuous glucose monitoring devices market based on sensors, transmitter & receiver, insulin pumps covering the revenue growth of each sub-segment from 2018 to 2030.
As per the IDF data 2021, the number of people with diabetes in Japan reached around 11 million. Type 1 diabetes is caused due to an immune system malfunction. However, a sedentary lifestyle, leading to inherent insulin resistance, causes type 2 diabetes. Japan has the greatest number of geriatric population, making them more susceptible to type 2 diabetes.
With the growing geriatric population, the prevalence of diabetes is expected to rise. Hence, people are increasingly monitoring and managing their blood glucose levels to avoid serious health issues, such as kidney disorders and cardiovascular diseases.
Furthermore, the Ministry of Health, Labor, and Welfare has identified diabetes as a healthcare priority due to its high prevalence and significant economic burden, especially type 2 diabetes. Patients with comorbidities, such as hypertension and hyperlipidemia, or those who develop complications have increased costs, which escalate with the number of complications.
Horizon Databook provides a detailed overview of country-level data and insights on the Japan continuous glucose monitoring devices market , including forecasts for subscribers. This country databook contains high-level insights into Japan continuous glucose monitoring devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account